Friday – Clinical Track 6A Survey

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Neuronal hypotheses and data on the mechanisms of action of botulinum toxin injections in psychiatric disorders
Tillmann H. C. Krüeger, MD (Germany)
Botulinum toxin as a treatment for depression – current data situation
Marc Axel Wollmer, MD (Germany)
OnabotulinumtoxinA in resistant depression: A new paradigm comparing two facial injection sites (OnaDep study)
Danièle Ranoux, MD (France)
YesNo
Neuronal hypotheses and data on the mechanisms of action of botulinum toxin injections in psychiatric disorders
Tillmann H. C. Krüeger, MD (Germany)
Botulinum toxin as a treatment for depression – current data situation
Marc Axel Wollmer, MD (Germany)
OnabotulinumtoxinA in resistant depression: A new paradigm comparing two facial injection sites (OnaDep study)
Danièle Ranoux, MD (France)
YesNo
Neuronal hypotheses and data on the mechanisms of action of botulinum toxin injections in psychiatric disorders
Tillmann H. C. Krüeger, MD (Germany)
Botulinum toxin as a treatment for depression – current data situation
Marc Axel Wollmer, MD (Germany)
OnabotulinumtoxinA in resistant depression: A new paradigm comparing two facial injection sites (OnaDep study)
Danièle Ranoux, MD (France)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care